BlackRock U.S. Impact Fund PACB Holdings History
Number of Shares
6,141.00
Current Holdings Value*
$81,120.00
% of Portfolio
1.45%
Total Estimate Gain
$-68,902.02
% of Total Estimate Gain
-86.91%
BlackRock U.S. Impact Fund's Pacific Biosciences of California Inc Holding Summary
As of 2023-07-31, BLACKROCK FUNDS held 6,141.00 shares of Pacific Biosciences of California Inc(PACB), totaling $81,120.00. This investment constitutes 1.45% of their stock portfolio, and BLACKROCK FUNDS now holds 0% of the outstanding Pacific Biosciences of California Inc(PACB) stock.
The initial trade took place in 2023Q3. And since then BlackRock U.S. Impact Fund has made 1 purchases of PACB, at an average price of $12.91, for a total of 6,141.00 shares. Based on historical transaction data and PACB's current price of $1.69, BlackRock U.S. Impact Fund's estimated gain on his PACB holdings is $-68,902.02, reflecting a -86.91% gain to date.
BlackRock U.S. Impact Fund PACB ($1.69) Holding Chart
BlackRock U.S. Impact Fund PACB ($1.69) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1